Safety with ocrelizumab in rheumatoid arthritis: results from the ocrelizumab phase III program
Emery, Paul, Rigby, William, Tak, Paul P, Dörner, Thomas, Olech, Ewa, Martin, Carmen, Millar, Laurie, Travers, Helen, Fisheleva, Elena
Published in PloS one (03.02.2014)
Published in PloS one (03.02.2014)
Get full text
Journal Article
Efficacy and safety of adjunctive bitopertin versus placebo in patients with suboptimally controlled symptoms of schizophrenia treated with antipsychotics: results from three phase 3, randomised, double-blind, parallel-group, placebo-controlled, multicentre studies in the SearchLyte clinical trial programme
Bugarski-Kirola, Dragana, Iwata, Nakao, Sameljak, Snjezana, Reid, Carol, Blaettler, Thomas, Millar, Laurie, Marques, Tiago Reis, Garibaldi, George, Kapur, Shitij
Published in The Lancet. Psychiatry (01.12.2016)
Published in The Lancet. Psychiatry (01.12.2016)
Get more information
Journal Article
Cerebellar Mechanisms in Eyeblink Conditioning
ATTWELL, PHILIP J.E., IVARSSON, MAGNUS, MILLAR, LAURIE, YEO, CHRISTOPHER H.
Published in Annals of the New York Academy of Sciences (01.12.2002)
Published in Annals of the New York Academy of Sciences (01.12.2002)
Get full text
Journal Article
2126. Safety, Tolerability, and Pharmacokinetics (PK) in Healthy Participants Following Single Dose Administration of Zosurabalpin, a Novel Pathogen-Specific Antibiotic for the Treatment of Serious Acinetobacter Infections
Guenther, Andreas, Millar, Laurie, Messer, Amanda, Giraudon, Mylène, Patel, Katie, Deurloo, Erik J, Lobritz, Michael, Gloge, Andreas
Published in Open forum infectious diseases (27.11.2023)
Published in Open forum infectious diseases (27.11.2023)
Get full text
Journal Article
O1‐02‐04: BASELINE CHARACTERICS FROM A PHASE 3 TRIAL OF CRENEZUMAB IN PRODROMAL TO MILD ALZHEIMER'S DISEASE (CREAD)
Lin, Helen, Ostrowitzki, Susanne, Sink, Kaycee M., Millar, Laurie, Warren, Francis, Smith, Jillian, Schneider, Andres, Fuji, Reina N., Quartino, Angelica, Mackey, Howard, Rabbia, Michael A., Yule, Susan, Fontoura, Paulo, Doody, Rachelle
Published in Alzheimer's & dementia (01.07.2018)
Published in Alzheimer's & dementia (01.07.2018)
Get full text
Journal Article
BASELINE CHARACTERICS FROM A PHASE 3 TRIAL OF CRENEZUMAB IN PRODROMAL TO MILD ALZHEIMER’S DISEASE (CREAD)
Lin, Helen, Ostrowitzki, Susanne, Sink, Kaycee M., Millar, Laurie, Warren, Francis, Smith, Jillian, Schneider, Andres, Fuji, Reina N., Quartino, Angelica, Mackey, Howard, Rabbia, Michael A., Yule, Susan, Fontoura, Paulo, Doody, Rachelle
Published in Alzheimer's & dementia (01.07.2018)
Published in Alzheimer's & dementia (01.07.2018)
Get full text
Journal Article
Safety with Ocrelizumab in Rheumatoid Arthritis: Results from the Ocrelizumab Phase III Program: e87379
Emery, Paul, Rigby, William, Tak, Paul P, Dorner, Thomas, Olech, Ewa, Martin, Carmen, Millar, Laurie, Travers, Helen, Fisheleva, Elena
Published in PloS one (01.02.2014)
Published in PloS one (01.02.2014)
Get full text
Journal Article